The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App 
Professionals >> Visit The Body PROThe Body en Espanol
  • Email Email
  • Comments Comments
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

FDA Approval of Generic ARVs

July/August 2011

Since the last issue of HTB, the U.S. Food and Drug Administration (FDA) has granted tentative approval (or full approval*) for the following new generic ARV products.

Drug and formulation Manufacturer, Country Approval date
AZT/3TC tablets, 300 mg/150 mg Teva, USA* 25 May 2011
Tenofovir DF tablets, 300 mg Strides, India 25 May 2011
Abacavir/3TC scored tablets, 60 mg/30 mg Cipla, India 12 May 2011

FDC: Fixed-Dose Combination

Effective patent dates are listed in the agency's publication titled Approved Drug Products with Therapeutic Equivalence Evaluations, also known as the Orange Book:

An updated list of generic tentative approvals is available on the FDA website:


FDA list serve:

* Full approval enables this generic to be sold in the U.S.

Links to external websites are current at time of posting but not maintained.


  • Email Email
  • Comments Comments
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

This article was provided by HIV i-Base. It is a part of the publication HIV Treatment Bulletin. Visit HIV i-Base's website to find out more about their activities, publications and services.
See Also
More on the FDA Drug Approval Process and Other Regulatory Issues

No comments have been made.

Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read's Comment Policy.)

Your Name:

Your Location:

(ex: San Francisco, CA)

Your Comment:

Characters remaining: